Search

everythinglearnresearchcommunity

for

Search:↓

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

CS12192 effectively treats alopecia areata with better safety than current options.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Diabetex improves diabetic wound healing better than metformin.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Low selenium intake may delay puberty in boys but not in girls.

The new biomimetic skin heals wounds faster and better than traditional treatments, without scarring.

Vitamin B complex improves plastic and cosmetic surgery outcomes by enhancing tissue repair and reducing inflammation.

Functional nutrition evaluations can improve personalized wellness programs and help prevent chronic diseases.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Dutasteride works better than finasteride for hair loss, with both being safe to use.